Get started
Work

Advances and Future Directions in Molecular Breast Imaging

Year: 2021
Type: article
Abstract: Tc-sestamibi has advanced rapidly over the past decade. Technical advances allow lower-dose, higher-resolution imaging and biopsy capability. MBI can be used for supplemental breast cancer screening with mammography for women with dense breasts, as well as to assess neoadjuvant therapy response, evaluate disease extent, and predict breast cancer risk. This article highlights the current state of the art and future directions in MBI.
DOI: 10.2967/jnumed.121.261988
Institutions: University of Utah, Huntsman Cancer Institute, Mayo Clinic, Mayo Clinic in Florida, Brown University, Rhode Island Hospital, The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4200467978
FWCI: 2.269
Cites: 47
Cited by: 25
Related to: 10